Hostname: page-component-77c89778f8-swr86 Total loading time: 0 Render date: 2024-07-20T22:10:04.053Z Has data issue: false hasContentIssue false
  • English
  • Français

A 58-year-old woman with progressive vertigo, deafness and weakness

Published online by Cambridge University Press:  02 December 2014

D.J. Chong ,
M.J. Strong ,
M.J. Shkrum ,
P. Kalapos  and
R.R. Hammond
D.J. Chong
Affiliation:
Department of Clinical Neurological Sciences, Division of Neurology, University of Western Ontario, London ON, Canada
M.J. Strong
Affiliation:
Department of Pathology and the Department of Clinical Neurological Sciences, Division of Neurology, University of Western Ontario, London ON, Canada
M.J. Shkrum
Affiliation:
Department of Pathology and the Department of Clinical Neurological Sciences, Division of Neurology, University of Western Ontario, London ON, Canada
P. Kalapos
Affiliation:
Department of Radiology, Division of Neurology, University of Western Ontario, London ON, Canada
R.R. Hammond
Affiliation:
Department of Pathology, Division of Neurology, University of Western Ontario, London ON, Canada
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Neuropathological Conference
Information
Canadian Journal of Neurological Sciences , Volume 32 , Issue 1 , February 2005 , pp. 103 - 108
Copyright
Copyright © The Canadian Journal of Neurological 2014

References

1. Graus, F, Keime-Guibert, F, Reñe, R, et al. Anti-Hu-associatedparaneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001; 124: 1138–1148.Google Scholar
2. Giometto, B, Taraloto, B, Graus, F. Autoimmunity in paraneoplasticneurological syndromes. Brain Pathol 1999; 9: 261–273.Google Scholar
3. Sutton, I. Paraneoplastic neurological syndromes. Curr Opin Neurol 2002; 15: 685–690.Google Scholar
4. Vincent, A. Antibodies to ion channels in paraneoplastic disorders. Brain Pathol 1999; 9: 285–291.Google Scholar
5. Dalmau, J, Gultekin, HS, Posner, JB. Paraneoplastic neurologicsyndromes: pathogenesis and physiopathology. Brain Pathol 1999; 15: 275–284.Google Scholar
6. Ehrenstein, MR. Antinuclear antibodies and lupul: causes andconsequences. Rheumatology (Oxford) 1999; 38: 691–696.Google Scholar
7. Rene, R, Ferrer, I, Graus, F. Clinical and immunohistochemicalcomparison of in vivo injected anti-Hu and control IgG in the nervous system of the mouse. Eur J Neurol 1987; 3: 319–323.CrossRefGoogle Scholar
8. Sillevis, Smitt PA, Manley, GT, Posner, JB. Immunization with theparaneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice. Neurology. 1995; 45(10): 1873–1878 Google Scholar
9. Schäfer, KH, Klotz, M, Mergner, D, et al. IgG-mediated cytotoxicityto myenteric plexus cultures in patients with paraneoplastic neurological syndromes. J Autoimmun 2000; 15: 479–484 CrossRefGoogle ScholarPubMed
10. Tanaka, K, Tanaka, M, Inuzuka, T, Nakano, R, Tsuji, S. Cytotoxic Tlymphocyte-mediated cell death in paraneoplastic sensory neuronopathy with anti-Hu antibody. J Neurol Sci 1999; 163: 159–162.Google Scholar
11. Neumann, H, Cavalie, A, Jenne, DE, Wekerle, H. Induction of MHCclass I genes in neurons. Science 1995; 269: 549–552.Google Scholar
12. Corriveau, RA, Huh, GS, Shatz, CJ. Regulation of class I MHC geneexpression in the developing and mature CNS by neural activity. Neuron 1998; 21: 505–520.Google Scholar
13. Grisold, W, Drlicek, M, Liszka-Setinek, U, Wondrusch, E. Anti-tumour therapy in paraneoplastic neurological disease. Clin Neurol Neurosurg 1995; 97: 106–111.Google Scholar
14. Keime-Guibert, F, Graus, F, Fleury, A, et al. Treatment ofparaneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry 2000; 68(4): 479–482.Google Scholar
15. Keime-Guibert, F, Graus, F, Broet, P, et al. Clinical outcome ofpatientswith anti-Hu-associated encephalomyelitis aftertreatment of the tumour. Neurology 1999; 53: 1719–1723.Google Scholar
16. Sillevis, Smitt P, Grefkens, J, de Leeuw, B, et al. Survival andoutcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy. J Neurol 2002; 249: 745–753.Google Scholar